Medicine and Dentistry
Hepatocellular Carcinoma
100%
Liver Transplantation
85%
Living Donor
85%
Recurrence Free Survival
59%
Retrospective Study
59%
Overall Survival
50%
Surgical Margin
50%
Blood Transfusion
50%
Odds Ratio
45%
Retrospective Cohort Study
42%
Laceration
42%
N [1 Cyclohexyl 2 [2 [4 (4 Fluorobenzoyl) 2 Thiazolyl] 1 Pyrrolidinyl] 2 Oxoethyl] 2 (Methylamino)propanamide
42%
Segmentectomy
42%
Liver Tumor
42%
Artery Ligation
42%
Portal Vein Blood Flow
42%
Lochia
42%
Laparoscopic Surgery
42%
Splenectomy
42%
Hemodynamic
42%
Liver Injury
42%
Virus
42%
Traumatic Brain Injury
42%
Tumor Recurrence
42%
Polytrauma
42%
Spleen Injury
42%
Surgeon
42%
Neoplasm
37%
Glasgow Coma Scale
35%
Resuscitation
31%
Abbreviated Injury Scale
28%
Recurrent Disease
25%
Intensive Care Unit
24%
Hemostat
24%
Trauma System
22%
Survival Rate
22%
Computer Assisted Tomography
21%
Fracture Fixation
21%
Hepatic Vein
21%
Lung Contusion
19%
Multivariate Analysis
17%
Hepatectomy
15%
Flail Chest
14%
Disease Free Survival
14%
Obstetrics
14%
Orthopedics
10%
Propensity Score Matching
10%
Internal Fixation
10%
Selection Bias
10%
Pulmonary Contusion
9%
Keyphrases
Graft Inflow Modulation
42%
Delayed Fixation
42%
NASH-related HCC
42%
Smac Mimetics
42%
Fractured Ribs
42%
Surgical Stabilization of Rib Fractures
42%
LCL161
42%
Maxillofacial Fractures
42%
Oronasal
42%
Volume Quantification
42%
Life-threatening Hemoptysis
42%
Parenchymal Injuries
42%
Margin Width
42%
Nonanatomic Resection
42%
Interhospital Transfer
42%
Splenic Injury
42%
Injury Care
42%
Middle Hepatic Vein
32%
Flail Chest
21%
Lung Contusion
17%
Hemopneumothorax
12%
Team-based Approach
12%
Hit Phenomena
10%
Delayed Fracture
10%
Patient Transfer
10%
Trauma Systems
10%
Liver Preservation
10%
Three-dimensional Reconstruction Model
10%
Pulmonary Contusion
8%
Hysterectomy Rate
7%
Lethal Triad
7%
Haemostatic Intervention
7%
Team Expertise
7%
Blunt Thoracic Trauma
7%
Propensity Score Model
7%
Facial Anatomy
7%
Surgical Hemostasis
7%
PRBC
7%
GCS Score
7%
Maxillofacial Bleeding
7%
Oral Intubation
7%
Early Tumor Recurrence
6%
Haemostatic Treatment
6%
Hemostatic Procedure
6%
Hospital-free Days
6%